Effect of long-term stabilization of cationic liposomes as defibrotide delivery system for antithrombotic activity

Drug Development Research

Volumn 55, Issue 2, 2002, Pages 127-138

  Esposito, Elisabetta ^a   Cortesi, Rita ^a   Porta, Roberto ^b   Trento, Fabio ^b   Nastruzzi, Claudio ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b Crinos Industria Farmacobiologica SpA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Defibrotide; Delivery; Freeze drying; Hypertension control; Liposome

Indexed keywords

ANTICOAGULANT AGENT; CARBOHYDRATE; CATION; CRYOPROTECTIVE AGENT; DEFIBROTIDE; LIPOSOME; MANNITOL; SORBITOL; SUCROSE;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; FREEZE DRYING; IN VITRO STUDY; IN VIVO STUDY; MALE; MORPHOLOGY; NONHUMAN; RAT; REHYDRATION;

EID: 0036242145     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10041     Document Type: Article

References (34)

1. Human gene therapy
2. Stabilization of liposomes by freeze-thaw- and lyophilization techniques: Problems and opportunities
3. Effects of defibrotide on aorta and brain malondialdehyde and antioxidants in cholesterol-induced atherosclerotic rabbits
4. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes
5. Clinical trials with defibrotide in vascular disorders
6. Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA
7. Formulatory study for the antitumor drug camptothecin: Liposomes, micellar solutions and microemulsion
8. Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes
9. Factors affecting the stability of dry liposomes
10. Stabilization of dry phospholipid bilayers and proteins by sugars
11. Is trehalose special for preserving dry biomaterials: Biophys J
12. Stabilization of dry membranes by mixtures of hydroxyethyl starch and glucose: The role of vitrification
13. Antithrombotic drugs in the primary medical management of intermittent claudication: A meta-analysis
14. Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide
15. Fate of cationic liposomes and their complex with oligonucleotide in-vivo
16. Synthetic DNA delivery systems
17. Vesicles of variable size produced by a rapid extrusion procedure
18. Pharmacological management of peripheral vascular-disease
19. 2-generation and antithrombotic activity of orally administered defibrotide
20. Cryoprotective effects of cycloinulohexaose on freezing and freeze-drying of liposomes
21. Pharmacological reduction of factor-XIII activity and fibrinogenemia in patients with peripheral arterial occlusive disease
22. From genes to gene medicines: Recent advances in non viral gene delivery
23. Protective effect of defibrotide on perfusion induced endothelial damage
24. Simulated lung transfection by nebulization of liposome cDNA complexes using a cascade impactor seeded with 2-CFSMEO-celIs
25. Liposomes in drug delivery: Progress and limitations
26. Novel beneficial-effects of difibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated-perfused rat-heart
27. Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo
28. Stability of dry liposomes in sugar glasses
29. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation
30. Controllable gene therapy. Pharmaceutics of non-viral gene delivery systems
31. Interaction of the endothelial mediators, NO e PGI2, on the regulation of blood pressure in anaesthetized rats
32. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation
33. Stable and monodisperse lipoplex formulations for gene delivery